Scroll to top
© 2020, Startuprecipe theme by Rssow

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

2023/09/12

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

News Summary: Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. New pre-developed LC-MS analytical workflows make it even easier for...

2023/09/12

KX ANNOUNCES KDB.AI CLOUD: THE FREE, SMARTER VECTOR DATABASE FOR AI

NEW YORK, and LONDON, Sept. 12, 2023 /PRNewswire/ — KX, the global pioneer in vector and time-series data management, has announced the general availability of KDB.AI Cloud, a vector database for real-time contextual AI. Quick and easy to set up...

2023/09/12

Hisense Brings Consumers with A Scenario-driven Home Cinema Experience

QINGDAO, China, Sept. 12, 2023 /PRNewswire/ — Hisense, the global consumer electronics and appliances corporation showcased its conception of scenario-driven and user-centric in product innovations at the world’s largest trade show IFA 2023, and demonstrated its latest Laser TV lineup...

2023/09/12

Exploring AI's Impact on Biotech Breakthroughs and International Funding

TAIPEI, Sept. 12, 2023 /PRNewswire/ — During BIO Asia-Taiwan 2023, GeneOnline and Ching Cheng Attorneys at Law jointly held a Biotech Month Forum, with the theme of "From AI to cross-border funding: Unlocking Success for Biotech Companies". Experts from various fields...

2023/09/12

Exness monthly trading volume reaches record-breaking $4.5 trillion

LIMASSOL, Cyprus, Sept. 12, 2023 /PRNewswire/ — Multi-asset broker Exness has reported a record-breaking $4.521 trillion in monthly trading volume and 625,626 active clients for August. Exness Headquarters, Limassol, Cyprus These results follow July’s record-breaking $3.91 trillion trading volume and 571,380...

2023/09/12

Tencent Cloud Launches Inaugural Web3 Product Tencent Cloud Blockchain RPC for Developers and Enterprises

New release emphasizes Tencent Cloud’s ongoing commitment to supporting the Web3 development HONG KONG, Sept. 12, 2023 /PRNewswire/ — Tencent Cloud, the cloud business of global technology company Tencent, today announced the launch of its first Web3-native product, Tencent Cloud...

2023/09/12

Charting a Green Future: GCLSI Takes Center Stage at International Forum on Energy Transition

SUZHOU, China, Sept. 12, 2023 /PRNewswire/ — GCL System Integration Technology Co., Ltd. ("GCLSI") commanded a leading role at the 4th International Forum on Energy Transition, held at the International Conference Hotel in Suzhou, China from September 5th to 7th,...

2023/09/12

Vertex Ventures Southeast Asia and India Partnership completes Final Close of Fund V at USD 541 Million exceeding its target fund size of USD 450 Million

SINGAPORE, Sept. 12, 2023 /PRNewswire/ — Vertex Ventures Southeast Asia and India ("VVSEAI") is pleased to announce that it has completed the fund raising for its fifth and newest fund with commitments of USD 541 million. VVSEAI Fund V is...

2023/09/12

Seize opportunities for better future of Chinese science fiction

BEIJING, Sept. 12, 2023 /PRNewswire/ — A Report From GLOBAL TIMES ONLINE: I ventured into the realm of science fiction creation, deeply inspired by the wonders of science. I can still vividly recall the exhilaration I felt when reading the...

2023/09/12

Plug and Play announces Strategic Partnership with EDOTCO Group to Drive Innovation in the Telecommunications Industry

SINGAPORE, Sept. 12, 2023 /PRNewswire/ — Plug and Play, the world’s largest global innovation platform that connects startups, corporations, and investors, has announced a strategic partnership with EDOTCO Group Sdn Bhd (EDOTCO), a leading provider of integrated telecommunications infrastructure services...

2023/09/11

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

– Lunit’s collaborative study supports AI as a viable alternative to one human reader in Europe’s double reading system – published in The Lancet Digital Health SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of...

2023/09/11

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

SHENZHEN, China, Sept. 11, 2023 /PRNewswire/ — MGI, a company committed to building core tools and technology to lead life science, today announced the DCS Lab Initiative to help facilitate large-scale leading multi-omics laboratories and spur critical scientific research. Under...

2023/09/11

Global Times: BRI's emphasis on environmentally friendly practices has benefited Central Asia countries

BEIJING, Sept. 11, 2023 /PRNewswire/ –For ten years, China and Central Asian countries have been more tightly bonded together through cooperation in the traditional energy section under the Belt and Road Initiative (BRI). However, the rise of Chinese companies specializing...

2023/09/11

ATFX's MT4 Trading Volume Ranked Fifth Globally in the Second Quarter

KUALA LUMPUR, Malaysia , Sept. 11, 2023 /PRNewswire/ — Recently, Finance Magnates released its industry report for the second quarter of 2023. With a remarkable quarterly total trading volume exceeding $531 billion, ATFX has firmly secured the fifth position globally. Breaking...

2023/09/11

Delta Singapore Showcases Smart Green Building Automation, HVAC and Energy Solutions at MARVEX 2023

Featured key solutions include smart community management, sustainable building management platform, HVAC application, energy infrastructure and data centre solutions. SINGAPORE, Sept. 11, 2023 /PRNewswire/ — Delta Electronics, a global leader in power and building automation solutions, is thrilled to announce...

2023/09/11

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ — PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma...

Access to the latest Korean startup news and startup database for free

sign up for Startup Recipe newsletter